Increasing Penetration of New Therapies Drive Hemophilia Market - Key Players are Bayer Group, Pfizer & Shire PLC - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Hemophilia Market Report: 2016 Edition " report to their offering.

Hemophilia refers to a group of inherited genetic conditions that damages the body's capability to control blood clotting, which controls bleeding when a blood vessel breaks. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. Depending upon the clotting factor deficiency, there are several types of hemophilia such as:

  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
  • Von Willebrand disease
  • Hemophilia with Inhibitors.

The market is anticipated to be driven by key factors such as increasing penetration of recombinant factor VIII, increasing healthcare expenditure, emerging use of treatments in low income countries and increasing diagnosis rates. Some significant progresses of this industry include increasing adoption of prophylaxis therapy, introduction of extended half-life products etc. However, the growth of respective industry is faced by challenges such as high cost of treatments and high reluctance by patients to switch to new treatments/products.

Key Topics Covered:

1. Overview

2. Market Analysis

3. Market Dynamics

4. Competitive Landscape

5. Company Profiles

Companies Mentioned:

  • Bayer Group
  • Novo Nordisk
  • Pfizer Inc.
  • Shire PLC

For more information visit http://www.researchandmarkets.com/research/r3fln8/global_hemophilia

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hematology